- Home
- MDCX vs PLSM Comparison
MDCX vs PLSM Comparison
Compare MDCX & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCX | PLSM |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 14.4M |
| IPO Year | 2025 | 2025 |
Fundamental Metrics
Financial Performance| Metric | MDCX | PLSM |
|---|---|---|
| Price | $0.15 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 5.6M | 50.3K |
| Earning Date | 05-11-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $2.22 |
| 52 Week High | $2.78 | $12.97 |
Technical Indicators
Market Signals| Indicator | MDCX | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 29.90 | 44.74 |
| Support Level | $0.15 | $2.22 |
| Resistance Level | $0.19 | $2.88 |
| Average True Range (ATR) | 0.01 | 0.24 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 14.70 | 43.94 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
About PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.